Cambridge Investment Research Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-64,090
| Closed | -$955K | – | 3633 |
|
|
2025
Q1 | $955K | Buy |
64,090
+3,698
| +6% | +$55.1K | ﹤0.01% | 1903 |
|
|
2024
Q4 | $870K | Buy |
60,392
+5,037
| +9% | +$72.6K | ﹤0.01% | 1980 |
|
|
2024
Q3 | $877K | Sell |
55,355
-9,733
| -15% | -$154K | ﹤0.01% | 1945 |
|
|
2024
Q2 | $1M | Buy |
65,088
+6,565
| +11% | +$101K | ﹤0.01% | 1776 |
|
|
2024
Q1 | $959K | Buy |
58,523
+9,097
| +18% | +$149K | ﹤0.01% | 1760 |
|
|
2023
Q4 | $724K | Buy |
49,426
+5,869
| +13% | +$86K | ﹤0.01% | 1879 |
|
|
2023
Q3 | $628K | Buy |
43,557
+13,683
| +46% | +$197K | ﹤0.01% | 1905 |
|
|
2023
Q2 | $491K | Buy |
29,874
+5,597
| +23% | +$92K | ﹤0.01% | 2146 |
|
|
2023
Q1 | $406K | Buy |
24,277
+2,278
| +10% | +$38.1K | ﹤0.01% | 2241 |
|
|
2022
Q4 | $339K | Buy |
21,999
+264
| +1% | +$4.07K | ﹤0.01% | 2331 |
|
|
2022
Q3 | $325K | Sell |
21,735
-3,814
| -15% | -$57K | ﹤0.01% | 2296 |
|
|
2022
Q2 | $420K | Buy |
25,549
+2,069
| +9% | +$34K | ﹤0.01% | 2092 |
|
|
2022
Q1 | $471K | Buy |
23,480
+6,407
| +38% | +$129K | ﹤0.01% | 2154 |
|
|
2021
Q4 | $433K | Sell |
17,073
-20,856
| -55% | -$529K | ﹤0.01% | 2224 |
|
|
2021
Q3 | $1.02M | Buy |
37,929
+1,535
| +4% | +$41.4K | 0.01% | 1499 |
|
|
2021
Q2 | $1.05M | Buy |
36,394
+3,325
| +10% | +$96.2K | 0.01% | 1495 |
|
|
2021
Q1 | $870K | Buy |
33,069
+8,377
| +34% | +$220K | ﹤0.01% | 1527 |
|
|
2020
Q4 | $707K | Buy |
24,692
+7,825
| +46% | +$224K | ﹤0.01% | 1538 |
|
|
2020
Q3 | $402K | Buy |
16,867
+4,477
| +36% | +$107K | ﹤0.01% | 1745 |
|
|
2020
Q2 | $259K | Buy |
+12,390
| New | +$259K | ﹤0.01% | 1998 |
|